What is the maximum daily dose of ivermectin for an average adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Daily Dose of Ivermectin

For standard parasitic infections in adults, the maximum daily dose of ivermectin is 200 mcg/kg as a single dose, though higher doses up to 600 mcg/kg/day for 3 consecutive days have been studied and found safe in clinical trials. 1, 2, 3

Standard Maximum Dosing by Clinical Context

FDA-Approved Maximum Dose

  • The FDA label documents that ivermectin has been studied at doses ranging from 30 to 120 mg (333 to 2000 mcg/kg) in healthy volunteers, demonstrating dose-proportional pharmacokinetics and tolerability. 2
  • The standard therapeutic dose remains 200 mcg/kg as a single oral dose for most approved indications. 1, 4

Guideline-Recommended Maximum Doses by Indication

Single-Dose Regimens:

  • For strongyloidiasis, cutaneous larva migrans, and most parasitic infections: 200 mcg/kg as a single dose 5, 1, 4
  • For pediculosis pubis: 250 mcg/kg, repeated in 2 weeks 1
  • For head lice (off-label): 400 mcg/kg on days 1 and 8 1

Multi-Day Regimens (Higher Total Exposure):

  • For Loeffler's syndrome: 200 mcg/kg once daily for 3 consecutive days 1
  • For immunocompromised patients with strongyloidiasis: 200 mcg/kg on days 1,2,15, and 16 1, 4
  • For onchocerciasis: 200 mcg/kg monthly for 3 months (combined with doxycycline) 5, 4
  • For crusted (Norwegian) scabies: 200 mcg/kg on days 1,2,8,9, and 15 (requires specialist consultation) 1

Research-Supported Higher Doses

Clinical Trial Evidence:

  • Doses up to 600 mcg/kg/day for 3 consecutive days have been studied in malaria transmission reduction trials and found to be safe and well-tolerated. 3
  • Single doses up to 800 mcg/kg have been used for onchocerciasis treatment. 3
  • The FDA label confirms that doses up to 2000 mcg/kg have been administered in pharmacokinetic studies without significant safety concerns. 2

Critical Safety Considerations

Absolute Contraindications to Higher Doses

  • Children under 10 years or weighing <15 kg: Ivermectin may cross the blood-brain barrier and cause neurotoxicity in young children; permethrin is recommended instead. 1, 4
  • Loiasis co-infection: Always exclude Loa loa infection before treating with ivermectin in anyone who has traveled to endemic regions, as hypermicrofilaremic patients (>8,000 mf/mL) risk severe adverse events including encephalitis. 1, 4

Special Population Warnings

  • Elderly and debilitated patients: One study demonstrated increased mortality in this population, though not confirmed in subsequent reports; use with caution. 4
  • Severe hepatic impairment: Use with extreme caution, as safety of multiple doses is not established. 1
  • Renal impairment: No dose adjustments required. 1, 4

Common Pitfalls to Avoid

  • Forgetting repeat doses: For scabies, the 2-week repeat dose at 200 mcg/kg is mandatory due to limited ovicidal activity. 1
  • Incorrect food timing: Standard dosing should be taken on an empty stomach with water for optimal bioavailability, though scabies treatment specifically requires administration with food to enhance epidermal penetration. 1, 4
  • Inadequate screening: Always exclude loiasis before treating lymphatic filariasis or onchocerciasis, and exclude onchocerciasis before treating loiasis. 4
  • Premature concern about treatment failure: Itching may persist for up to 2 weeks after successful treatment due to allergic dermatitis, not treatment failure. 1, 6

References

Guideline

Ivermectin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ivermectin Tablet Dosing for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ivermectin Safety Profile

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.